Accuray Incorporated Stock News

Despite strong product demand, Accuray (ARAY) reports an overall soft Q3 performance.

Despite strong product demand, Accuray (ARAY) reports an overall soft Q3 performance.

ARAY earnings call for the period ending March 31, 2022.

Accuray (ARAY) delivered earnings and revenue surprises of 83.33% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Accuray Incorporated (NASDAQ:ARAY ) Q3 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Ken Mobeck – Vice President-Finance Josh Levine – Chief Executive Officer Suzann

SUNNYVALE, Calif. , April 13, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2022, ended March 31, 2022, after the market

Latest data indicates that Accuray's (ARAY) CyberKnife System is effective in providing long-lasting pain relief to patients suffering from TN.

Latest data indicates that Accuray's (ARAY) CyberKnife System is effective in providing long-lasting pain relief to patients suffering from TN.

Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.

Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.

ARAY, AKU, and ANIK have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2022

ARAY, AKU, and ANIK have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2022

Pune, March 15, 2022 (GLOBE NEWSWIRE) -- According to the new report published by The Brainy Insights, the global veterinary oncology market is expected to grow from USD 186.96 million in 2020 to USD 611.09 million by 2028 at a CAGR of 10.8% during the forecast period 2021-2028. Get a Sample Copy of the Report at: https://www.thebrainyinsights.com/enquiry/sample-request/12587 In the near future the global market for veterinary oncology is projected to experience rapid expansion. The market is serving a rising need for pets to treat cancerous ailments. This is a rising issue, since various types of cancers are now increasing among pets. Additionally, therapies such as chemotherapy and radiation therapy are considered to have performed in many cancer stages, rendering them feasible solutions forthese critical life-saving applications.Also, rising regulatory approvals for veterinary oncology products is anticipated to drive the market growth. Veterinary oncology is a subspecialty of the veterinary medicine that deals with the diagnosis and treatment of animal cancer.

The oncology information system (OIS) is a comprehensive information and image management solution that facilitates the management and optimization of cancer patient profiles and treatments. The global OIS market is categorized based on product and service into software and services. The

Accuray's (ARAY) CyberKnife S7 System gets selected by the CARTI medical care team, thereby offering better cancer care in Arkansas via expanded access to advanced technology.